Soleine Medjebar

发表

Angiotensin-converting enzyme (ACE) inhibitor prescription affects non-small-cell lung cancer (NSCLC) patients response to PD-1/PD-L1 immune checkpoint blockers

Jean-David Fumet, F. Ghiringhelli, C. Richard, 2020, Oncoimmunology.

Efficacy of immune checkpoint inhibitors in older patients with non-small cell lung cancer: Real-world data from multicentric cohorts in Canada and France.

F. Ghiringhelli, C. Richard, M. Messaoudene, 2020, Journal of geriatric oncology.